BLLN Competitors & Alternatives

Compare BillionToOne, Inc. Class A Common Stock with similar stocks in the same industry

Diagnostics & Research

BLLN

Main Stock
$96.31
-8.41%
Tradestie Score
35
P/E Ratio
114.3
Revenue Growth
47.2%
Analyst Upside
+33.2%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 6/10 Genomics Precision Med Genomic Sequencing
Competitive Moat: Oligopoly
Core Technology Stack: Quantitative Counting Template (QCT), cfDNA molecular counting
Major Customers 4
OB/GYN clinics Hospitals Prenatal care providers Diagnostic laboratories
Critical Suppliers 3
Illumina Thermo Fisher Scientific Reagent manufacturers
Direct Ecosystem Rivals 2

Top Competitors

38 stocks in Diagnostics & Research
Company Price Market Cap P/E Score Action
GH Guardant Health, Inc. Common Stock
$144.03
-5.06%
$7.81B - 48 Compare
RDNT RadNet, Inc. Common Stock
$76.89
+0.62%
$6.00B - 45 Compare
SHC Sotera Health Company Common Stock
$16.25
-2.17%
$4.60B 27.7 60 Compare
HNGE Hinge Health, Inc.
$121.29
+5.11%
$3.82B 31.3 41 Compare
WGS GeneDx Holdings Corp. Class A Common Stock
$51.02
-2.58%
$3.26B - 50 Compare
HTFL Heartflow, Inc. Common Stock
$46.86
-3.30%
$3.00B 72.3 53 Compare
VCYT Veracyte, Inc.
$24.01
-1.32%
$2.85B 15.8 47 Compare
GRAL GRAIL, Inc. Common Stock
$105.60
-8.88%
$2.24B - 55 Compare
ADPT Adaptive Biotechnologies Corporation Common Stock
$27.87
-4.03%
$2.22B - 45 Compare
TWST Twist Bioscience Corporation Common Stock
$105.04
-5.88%
$1.77B - 52 Compare

Data updated: Nov 16, 2026 | Industry: Diagnostics & Research (SIC None)

38 stocks in this industry